Keyphrases
Overall Survival
100%
Breast Cancer
100%
Disease-free Survival
100%
Stage II-III
100%
Zoledronic Acid
100%
Neoadjuvant
100%
Hazard Ratio
42%
Confidence Interval
28%
Tumor
28%
Recurrent Disease
28%
High Risk
14%
Breast Cancer Patients
14%
No Significant Difference
14%
Chemotherapy
14%
Adjuvant Therapy
14%
Recurrence Rate
14%
Adjuvant Chemotherapy
14%
Cancer Outcomes
14%
Time Since Death
14%
Chemotherapy Cycles
14%
Patients with Breast Cancer
14%
Acid Control
14%
ER-negative
14%
Estrogen Receptor (ER) Status
14%
Medicine and Dentistry
Overall Survival
100%
Clinical Stage
100%
Breast Cancer
100%
Disease Free Survival
100%
Zoledronic Acid
100%
Recurrent Disease
57%
Hazard Ratio
42%
Neoplasm
28%
Malignant Neoplasm
14%
Arm
14%
Estrogen Receptor
14%
Adjuvant Therapy
14%
Adjuvant Chemotherapy
14%
Pharmacology, Toxicology and Pharmaceutical Science
Overall Survival
100%
Disease Free Survival
100%
Breast Cancer
100%
Zoledronic Acid
100%
Recurrent Disease
57%
Chemotherapy
42%
Neoplasm
28%
Malignant Neoplasm
14%
Estrogen Receptor
14%